Patent classifications
A61M1/0281
System and method for automated platelet wash
A method for washing platelets includes introducing anticoagulant into a platelet product container, drawing re-anticoagulated platelet product from the platelet product container, and introducing it into a centrifuge bowl. The centrifuge bowl separates the platelets from the supernatant in which they are suspended. The method then washes the platelets by introducing wash solution into the centrifuge bowl. As the wash solution is introduced into the bowl, it displaces the supernatant from the bowl and into a waste container. The method then introduces platelet additive solution into the centrifuge bowl, which displaces the wash solution from the centrifuge bowl and into the waste container and further wash the platelets. The method then repeatedly accelerates and decelerates the centrifuge bowl to resuspend the platelets in the platelet additive solution.
Medical heating device having means for blocking flow of fluid
A heating device for blocking flow of air if the inside of a cartridge enters a negative-pressure state is provided. The device includes a cartridge upper plate having a fluid-guide member for guiding the flow of a fluid; a cartridge lower plate having an inlet, an outlet and another fluid-guide member positioned spaced apart from the fluid-guide member of the cartridge upper plate; a heater disposed between the cartridge upper plate and the lower plate and heating the fluid being guided by the fluid-guide members; air filters positioned outside the fluid-guide members and discharging air bubbles in the heated fluid into the atmosphere; and extension units which are provided on the cartridge upper and lower plates having film members and outflow and discharge passages and that keep the flow of fluid normal in the positive-pressure state and block the fluid movement pathway if a negative pressure occurs inside the cartridge.
INTEGRATED AUTOTRANSFUSION BOWL AND FLUID LINE ORGANIZER
An autotransfusion system for separating fluid constituents includes a centrifuge housing and a rotatable driving member mounted within the centrifuge housing. The rotatable driving member is configured to receive therein and rotationally engage any one of a plurality of centrifuge bowls with different heights. In some embodiments, the centrifuge bowl is integrated with a fluid line organizer to provide for easy and efficient organization of a plurality of different fluid lines incorporated into the autotransfusion system. In some embodiments, the centrifuge bowl and fluid line organizer are easily and efficiently coupled to the centrifuge housing for autotransfusion processing.
CELL PROCESSING SYSTEM AND METHOD WITH POST-SEPARATION CELL COUNT CONTROL
A cell processing system includes a processor connectable to a source container filled with a biological fluid and one or more wash media containers. The processor includes a separator connectable to the source container and a product container, the separator configured to separate the biological fluid from the source container into at least two streams. In addition, a controller is coupled to the processor and configured to: cause the separator to separate the biological fluid into at least two streams, direct one of the at least two streams into the product container, subsequently pause processing of the biological fluid, after pausing, determine a measured cell count in the product container, and add fluid to the product container from the wash media containers as a function of the measured cell count in the product container while the product container is connected to the wash media containers.
SYSTEMS AND METHODS FOR PRIMING A FLUID CIRCUIT
Methods and systems for priming a disposable fluid circuit for the processing of a biological fluid are disclosed. The methods and systems allow for variable and configurable priming of the flow path(s) leading to one or more biological fluid source containers.
Apparatus and methods for concentrating platelet-rich plasma
Apparatus and methods for concentrating platelet-rich plasma is described herein. One variation may generally comprise a tube having a length and defining a channel within and one or more ports located at a proximal end of the tube and in fluid communication with the channel. A plunger may slidably translatable within the channel while forming a seal against an inner surface of the channel and a float may have a pre-selected density and defining a concave interface surface, wherein the float is slidably contained within the channel such that the concave interface surface is in apposition to the one or more ports.
BLOOD SEPARATION SYSTEM AND BLOOD PRODUCTS
A blood filtering apparatus for recovering blood components from blood comprises an inlet for the blood; a cell filter configured for filtering a portion of the blood and retaining as a retentate a fraction of the blood containing red blood cells and platelets and passing as a filtrate a fraction of the blood, in particular mainly as plasma, containing platelets and being depleted of red blood cells. The cell filter has a pore size in a range of 2,0-3.0 micron. Further, a method and a blood product are provided.
SYSTEM AND A METHOD FOR OBTAINING AN IMPROVED PLASMA EXTRACT
A system and a method are disclosed for obtaining a plasma composition enriched with bioactive molecules such as growth factors and cytokines and depleted in contaminants such as viruses.
Systems and methods for detecting an empty WB container
A system and method are provided for separating previously-collected whole blood into a red blood cell fraction and a plasma fraction by which the container of previously-collected whole blood is determined to be empty based on using the combination of the measured gross weight of the container and a calculated fluid flow rate from the container, based on weigh scale feedback. Upon detection of the empty container, flow from the container is stopped.
Therapeutic Compositions for Viral-Associated Disease States and Methods of Making and Using Same
A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.